tiprankstipranks
Cidara Therapeutics (CDTX)
NASDAQ:CDTX

Cidara Therapeutics (CDTX) Financial Statements

701 Followers

Cidara Therapeutics Financial Overview

Cidara Therapeutics's market cap is currently ―. The company's EPS TTM is $-8.068; its P/E ratio is -1.46; Cidara Therapeutics is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-3.46. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 8.46M$ 12.72M---
Gross Profit$ 2.83M$ 12.72M---
EBIT$ -10.33M$ -7.94M$ -12.21M$ 2.53M$ -10.19M
EBITDA$ -10.08M$ -7.66M$ -11.81M$ 2.85M$ -10.29M
Net Income Common Stockholders$ -10.33M$ -8.17M$ -12.36M$ 2.53M$ -10.30M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 29.02M$ 48.67M$ 50.43M$ 47.98M$ 32.73M
Total Assets$ 52.72M$ 63.47M$ 67.99M$ 81.47M$ 47.59M
Total Debt$ 4.65M$ 4.36M$ 4.54M$ 1.00M$ 1.32M
Net Debt$ -24.37M$ -44.31M$ -45.89M$ -46.98M$ -31.41M
Total Liabilities$ 70.50M$ 55.43M$ 52.57M$ 54.90M$ 50.50M
Stockholders Equity$ -17.78M$ 8.04M$ 15.41M$ 26.84M$ -2.90M
Cash Flow-
Free Cash Flow$ -6.67M$ -1.76M$ 2.71M$ -10.99M$ -21.01M
Operating Cash Flow$ -6.64M$ -1.63M$ 2.82M$ -10.90M$ -21.00M
Investing Cash Flow$ -23.00K$ -126.00K$ -107.00K$ -94.00K$ -9.00K
Financing Cash Flow$ -93.00K-$ -261.00K$ 26.24M$ 664.00K
Currency in USD

Cidara Therapeutics Earnings and Revenue History

Cidara Therapeutics Debt to Assets

Cidara Therapeutics Cash Flow

Cidara Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis